Stand aside — setup invalidated
Setup score 0, but distribution days reach 5 or more — stand aside until the condition resets.
Simple research view
HIMS · Hims & Hers Health, Inc.
$27.59 -0.43% Oct 26 close
1 independent risk warning also present. Review before relying on the bullish setup.
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$HIMS
Hims & Hers Health, Inc.Hims & Hers Health, Inc. is a Medical/Nursing Services company in the Health Services sector.
⚠ Risk Signals
Head & Shoulders Top
Neckline ~30.29 has broken. Measured-move risk extends toward ~21.53; a fast reclaim of 30.29 would be a failed breakdown (often bullish).
Bearish structure on the daily chart — a heads-up for anyone holding, not a short signal. Does not affect the bullish setup score.
Market Structure
Trend structure: downtrend
Latest event: structure_shift
(bearish)
Support
27.31–27.54
· 4 touches · moderate
Resistance
35.78–35.99
· 3 touches · moderate
Resistance
31.79–31.85
· 3 touches · moderate
Resistance
29.82–30.02
· 3 touches · moderate
Momentum Turn Watch
Bollinger Squeeze + Lower-Band Support
Bollinger band width (12.9%) is in the bottom quartile of its last 120 sessions — Legend's width-percentile squeeze (not a TTM/Keltner squeeze), so volatility is compressed and a sharper move often follows. Price ($27.59) is holding just above the lower Bollinger band ($27.18; %B 11) — support at the bottom of the bands.
Early technical context only. Wait for price, volume, and the canonical setup trigger to confirm; this signal does not change readiness or the setup score.
Historical verdict · setup score 0/100 · data Oct 26 close · latest session
Stand aside — setup invalidated
Setup score 0, but distribution days reach 5 or more — stand aside until the condition resets.
Recent price action · daily
What would change this verdict
What needs to turn for this to become buyable — the top failing checks across the legend council:
- Minervini 1.1 Price > 150-day MA AND 200-day MA — Price $27.59, MA150 $28.49, MA200 $27.09
- Minervini 1.5 Price > 50-day MA — Price $27.59 vs MA50 $29.13
- O'Neil L: RS rank ≥ 80 (IBD leadership) — RS rank 20
- O'Neil C: Quarterly EPS acceleration ≥ 25%
- Weinstein Not extended from 52-week high (≤ 30% below) — 45.9% below 52-week high
- Weinstein Relative strength ≥ 60 — RS 20
Minority view — the council disagrees here
- Minervini: avoid Trend-template read: fails Price > 150-day MA AND 200-day MA.
- O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
- Weinstein: watch Stage-analysis read: Stage 2 is present; 4 supporting checks need improvement.
39
Weak
Legend Score · rates the stock
Weak (39/100) — held back by quality (smr-like)
Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.
- Relative Strength (25%) 19
- Trend Template (25%) 62
- Institutional Footprint (20%) 34
- EPS Growth (15%) 50
- Quality (SMR-like) (15%) 31
RS rank 20: lagging the market — leaders don't look like this. Trend template 5/8: mixed — some uptrend elements, some missing. Institutional score 34: mild distribution — sellers active. No recent earnings growth data — scored neutral. Quality 31: weak fundamentals (sales growth 31). Updated 2026-10-22.
Earnings
Pre-earnings setup
Next earnings
Monday, November 2, 2026
Report time not confirmed by the source
Deterministic evidence
HIMS-0.43%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
CatalystPending
Stock reactionNegative
Sector reactionWeak
Opening surgePending
Event riskEarnings-driven
Session internals Mixed
Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.
Vs prior close-0.43%
From the open-0.29%
Range position51%
GapNo gap
QQQ confirmationDiverging (+1.11%)
SMH confirmationDiverging (+2.74%)
Short-term conviction -2 points.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.
- QQQ, SMH moved against the stock — no index confirmation.
- A sourced earnings report is still pending inside the risk window; ordinary technical conviction is reduced until it is out.
Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.
More stats
52W Low
$13.74
Tight Wks
0
Base
B3
SMA 200
$27.09
RS Line vs High
-48.6%
RS Line Slope
-1.0% ▼
Group Rank
#28/65
ADR%
6.0%
ATR(14)
$1.90 (6.9%)
Vol Pace (live)
N/A
A/D Days
16A / 13D
A/D Rating
A
VDU Bars
0/10 d
Earnings
in 6d
HIMS Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Technical Analysis Report Card
$HIMS · $27.59 · as of 2026-10-26 · multi-factor read
24
/ 100
Reference read from price & volume only — the verdict at the top of the page decides the action.
Trend · Daily / Weekly / Monthly
Daily
▬ Sideways / consolidating
Weekly
▼ Downtrend
Monthly
▼ Downtrend
Moving Averages
50-day$29.13 ↓
100-day$30.43 ↓
200-day$27.09 ↑
Bullish (50 > 200)
RSI (14)
Reading43.8 · Bearish
Bearish momentum — sellers in control.
MACD (12/26/9)
StateBearish
Histogram-0.147
Bearish — MACD below its signal line and below zero. Histogram contracting.
Bollinger Bands (20,2)
%B / Width11% · 12.9%
Squeeze — volatility compressing
Near the lower band — under pressure or oversold. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.
Volume · Buyer vs Seller
Up/Down vol0.67 · Neutral
Rel volume0.56×
Pocket pivots · 10d1
5d vs 50d vol73%
Heavy vol up / down0 / 0
Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.
- Pocket pivot 7 sessions ago — up-day volume beat every down day of the prior 10 sessions.
Support & Resistance
R · $29.82swing level
R · $30.39swing level
R · $31.03swing level
Price · $27.59now
S · $27.34swing level
S · $26.73swing level
S · $26.33swing level
Fibonacci · Uptrend swing
23.6%$34.92
38.2%$32.36
50.0%$30.29
61.8%$28.22
78.6%$25.28
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for HIMS — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly downtrendMonthly downtrendAbove 200-day MA50/200 bullishRS 20 (laggard)
Want this read in a legend's voice?
Ask a Legend about HIMS
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (0/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.
Council consensus:
6 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini
Avoid
D
Trend-template read: fails Price > 150-day MA AND 200-day MA.
Passing evidence
1.2 150-day MA > 200-day MAMA150 $28.49 vs MA200 $27.09
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $29.13, MA150 $28.49, MA200 $27.09
Failing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $27.59, MA150 $28.49, MA200 $27.09
1.5 Price > 50-day MAPrice $27.59 vs MA50 $29.13
O'Neil
Avoid
D
CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
A: Annual earnings & revenue qualityRev +59.0%
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 20
C: Quarterly EPS acceleration ≥ 25%Data unavailable
Weinstein
Watch
D
Stage-analysis read: Stage 2 is present; 4 supporting checks need improvement.
partialStage 2 uptrend in progress — hold as long as price stays above the 30-week moving average.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $27.59 vs MA200 $27.09
Failing evidence
Not extended from 52-week high (≤ 30% below)45.9% below 52-week high
Relative strength ≥ 60RS 20
dennis
Watch
C
Turtle read: no Donchian signal. The system stays flat until price takes out the 20-day high.
Passing evidence
No breakdown below the 20-day channel20-day low $26.33
Volatility-unit sizing (1N ≈ 1% of equity)1N = $1.79 (6.50% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
zanger
Avoid
D
Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $31.73-$33.11; trail the rest
Trail on the 10/20-day MA10-day MA $28.59 · 20-day MA $29.05 — exit the remainder on a close below the trail
Failing evidence
Named Zanger pattern onlywatchlist_candidate is not one of Zanger's six
Not extended (≤5% above the breakout point)Data unavailable
zweig
Watch
D
Zweig read: part of his screen passes but not all: Reasonable price for the growth (P/E ≤ 35); Insider buying; Price strength (RS ≥ 70) — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Breadth momentum: 10-day A/D ratio10-day A/D 1.17 (2084 adv / 1781 dec) — participation expanding
Failing evidence
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 54.1x — no PEG or forward P/E stored
Insider buyingNo insider buying flagged
Livermore
Watch
C
Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$27.59
Detected patternwatchlist_candidate
Failing evidence
Relative strengthRS 20
Volume vs average0.56x
Darvas
Watch
C
Box-theory read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$27.59
Detected patternwatchlist_candidate
Failing evidence
Relative strengthRS 20
Volume vs average0.56x
Wyckoff
Watch
C
Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$27.59
Detected patternwatchlist_candidate
Failing evidence
Relative strengthRS 20
Volume vs average0.56x
Base & Breakout
Breakout follow-through
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▼ Falling
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net +1
Fundamentals & leadership quality — Minervini’s published criteria · 1/7 met
D
1/7 criteria
Separate score from the Minervini Trend Template (3/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
—
Revenue growth ≥20% YoY
+59%
Gross margin ≥30%
—
ROE ≥17%
—
RS rating ≥80 (leadership)
20
Stage 2 uptrend (Weinstein)
Stage 1
Within 25% of 52W high
-46.3%
Method Playbook
Trade it like Darvas
EXACT LEVELS · PRO
Darvas C · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro levelPublished-method rule: Use the top of the active Darvas box near the high as the mechanical breakout boundary.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Require price to clear the box top with volume confirmation; movement inside the box remains observation, not a trigger.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Start below the active box support or the canonical structural stop that proves the breakout failed.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: As higher boxes form, raise the stop beneath the newest confirmed box floor; the stop moves up only.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit when price breaks the active box floor or decisively falls back through the breakout structure.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis (historical)
0
setup score
RS Score
20
Trend template
3/8
Why This Setup?
watchlist_candidate · schematic
Near-miss 5/8 — needs: sma200 trending up, price within 25pct of 52w high, rs score above 70
The Universal Edge Check · context only
What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.
0/7
universals met
- A relative-strength leader — not met RS score 20 — laggard
- Clear of earnings — not met in 6 days — event risk
- In a confirmed uptrend — not met Stage 1 · Trend template 3/8 — no uptrend; don't bottom-fish
- Risk is defined — not met No stop — undefined risk
- Asymmetric reward — partly met No target set
- Not chasing (in range) — partly met Pivot distance unknown
- Volume confirms — partly met 0.6× average — light
Minervini Trend Template
3/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$27.59 vs SMA150 $28.49 / SMA200 $27.09
SMA 150 above SMA 200
SMA150 $28.49 vs SMA200 $27.09
SMA 200 trending up
Slope -0.61 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $29.13
Price above SMA 50
$27.59 vs SMA50 $29.13
30%+ above 52-week low
+100.8% from $13.74
Within 25% of 52-week high
-46.3% from $51.36
RS score above 70
RS 20
Fundamentals
52W Range
37%
Rev YoY
+59%
EPS TTM
$0.51
P/E TTM
54.1x
Insider
No Buy
Company
Company profile
Hims & Hers Health, Inc.
Scan History
Oct 22
watchlist_candidate
0
Oct 21
watchlist_candidate
0
-5.5%
Oct 16
watchlist_candidate
0
-1.7%
Oct 14
watchlist_candidate
0
-0.5%
Oct 13
watchlist_candidate
0
-7.1%
Oct 12
watchlist_candidate
0
-10.0%
Latest News
Headlines for HIMSLoading headlines…
Get the full picture on HIMS
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.
Start 7-Day Free Trial